The present invention provides RNA molecules (e.g., antisense, RNAi, or siRNA) specific for COX-2, and further provides methods of reducing expression of COX-2 in cells (e.g., cancer cells).

 
Web www.patentalert.com

< Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20

< Method and system for corn fractionation

> Antisense modulation of PTP1B expression

> Modulation of glucocorticoid receptor expression
~ 00236